Published in Infect Immun on July 01, 1976
Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50
Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med (1980) 5.23
Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro. Infect Immun (1982) 2.61
Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides. J Exp Med (1978) 2.45
Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili. Infect Immun (1982) 2.39
The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence. Immunology (1980) 2.33
Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77
Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J Clin Invest (1978) 1.66
X-linked inheritance in females with chronic granulomatous disease. J Clin Invest (1980) 1.35
Interactions between human granulocytes and Blastomyces dermatitidis. Infect Immun (1979) 1.21
Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis. J Clin Invest (1978) 1.15
Peritoneal macrophage activation indicated by enhanced chemiluminescence. Infect Immun (1978) 1.14
Chemiluminescence by human alveolar macrophages: stimulation with heat-killed bacteria or phorobol myristate acetate. Infect Immun (1977) 1.03
Temperature dependence of NADPH oxidase in human eosinophils. J Physiol (2003) 0.98
Phagocytosis by sheep alveolar macrophages: relationship between opsonin concentration and light emission in the presence of luminol. Infect Immun (1978) 0.94
Influenza A virus-induced polymorphonuclear leukocyte dysfunction. Infect Immun (1982) 0.92
Immunologic and nonimmunologic generation of superoxide from mast cells and basophils. J Clin Invest (1978) 0.88
Specificity and reversibility of chemotactic deactivation of human monocytes. Infect Immun (1981) 0.87
Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces. Infect Immun (1981) 0.86
Immunomodulation by Blastomyces dermatitidis: functional activity of murine peritoneal macrophages. Infect Immun (1983) 0.85
Simple procedure for measuring neutrophil chemiluminescence. J Clin Microbiol (1981) 0.82
Chemiluminescent responses of alveolar macrophages from normal and Mycobacterium bovis BCG-vaccinated rabbits as a function of age. Infect Immun (1987) 0.82
The chemiluminescence response of human platelets. J Clin Invest (1978) 0.79
Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest (1973) 17.56
The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest (1968) 10.35
Superoxide dismutases. Annu Rev Biochem (1975) 8.00
The properdin system and immunity. V. The bactericidal activity of the properdin system. J Exp Med (1956) 7.90
Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol (1968) 7.67
Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Anal Biochem (1969) 7.65
Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun (1972) 7.50
Phagocytosis by human monocytes. Blood (1968) 3.96
The metabolism of leukocytes. Semin Hematol (1968) 3.55
Superoxide production by phagocytic leukocytes. J Exp Med (1975) 3.43
Differentiation of monocytes. Origin, nature, and fate of their azurophil granules. J Cell Biol (1971) 2.86
Phagocytic and bacterial properties of normal human monocytes. J Clin Invest (1974) 2.65
The macrophage. Int Rev Cytol (1973) 2.52
The superoxide anion and singlet molecular oxygen: their role in the microbicidal activity of the polymorphonuclear leukocyte. Biochem Biophys Res Commun (1974) 2.50
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Impaired chemiluminescence during phagocytosis of opsonized bacteria. Infect Immun (1973) 2.35
The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest (1975) 2.26
Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26
Halide dependence of the myeloperoxidase-mediated antimicrobial system of the polymorphonuclear leukocyte in the phenomenon of electronic excitation. Biochem Biophys Res Commun (1975) 1.83
Singlet molecular oxygen from superoxide anion and sensitized fluorescence of organic molecules. Science (1970) 1.83
Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations. Lab Invest (1973) 1.60
The production of superoxide radical during the decomposition of potassium peroxochromate(V). Biochemistry (1974) 1.34
Quantitative assays of human monocyte-macrophage function. J Immunol Methods (1975) 1.23
Erythrocuprein and singlet oxygen. FEBS Lett (1972) 1.16
Drug potentiation of macrophage function. Infect Immun (1970) 1.08
Histidine at the active site of superoxide dismutase. Biochemistry (1973) 1.07
The generation of superoxide anion by various types of phagocyte. J Infect Dis (1975) 1.01
Lymphocytes bearing complement receptors, surface immunoglobulins and sheep erythrocyte receptors in primary immunodeficiency diseases. Clin Exp Immunol (1974) 0.99
Phagocytosis of heat-killed radiolabelled Candida albicans by human blood monocytes cultured in vitro. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 0.81
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60
alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell (1995) 4.99
Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1969) 4.12
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. J Immunol Methods (1977) 3.89
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet (1999) 3.73
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24
Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun (1978) 3.23
Opsonic, agglutinating, and complement-fixing antibodies in patients with subacute bacterial endocarditis. J Lab Clin Med (1968) 3.20
Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med (1971) 3.14
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA (1978) 3.13
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis. Proc Soc Exp Biol Med (1971) 3.11
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1977) 3.09
Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00
A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell (1995) 2.89
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun (1986) 2.80
Effect of protein A on staphylococcal opsonization. Infect Immun (1977) 2.79
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun (1989) 2.77
Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73
Antiphagocytic effects of staphylococcal protein A. J Immunol (1969) 2.59
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49
Immunodepression after major surgery in normal patients. Surgery (1975) 2.48
Cyclic GMP and cell movement. Nature (1973) 2.46
Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Influence of the alternate complement pathway in opsonization of several bacterial species. Infect Immun (1974) 2.34
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci. Pediatrics (1968) 2.31
An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24
Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of protein A residues on bacteria. J Immunol (1970) 2.19
Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect. Lancet (1967) 2.19
Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun (1979) 2.17
Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16
Detection and spatial distribution of the beta 2 integrin (Mac-1) and L-selectin (LECAM-1) adherence receptors on human neutrophils by high-resolution field emission SEM. J Histochem Cytochem (1993) 2.13
Opsonic activity of agammaglobulinemic human sera. J Immunol (1971) 2.13
Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology (1974) 2.08
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07
Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis (1974) 2.06
Cytochalasin B. IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes. J Immunol (1972) 2.04
Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun (1978) 2.03
Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00
Rheumatoid factors in subacute bacterial endocarditis--bacterium, duration of disease or genetic predisposition? Ann Intern Med (1968) 2.00
DNA fingerprinting of Streptococcus zooepidemicus (Lancefield group C) as an aid to epidemiological study. J Infect Dis (1987) 1.99
Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet (1974) 1.98
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
Human serum interactions with Candida albicans. J Immunol (1968) 1.93
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun (1977) 1.92
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr (1976) 1.83
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82
Pancreatic trauma: a review. Surgery (1972) 1.81
Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81
Phagocytosis in subacute bacterial endocarditis. Localization of the primary opsonic site to Fc fragment. J Exp Med (1968) 1.80
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. Metabolism (1975) 1.78
Family tension in the search for a kidney donor. JAMA (1971) 1.77
Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77
Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J Immunol (1988) 1.77
Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76
Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74
Effects of staphylococcal protein A on heat labile opsonins. J Immunol (1974) 1.73
Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun (1983) 1.70
Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69
Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69
Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun (1976) 1.63
California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun (1978) 1.56
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55
Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization. Infect Immun (1983) 1.54
Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol (1991) 1.54
Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood (1989) 1.53
Hemorrhagic shock. Curr Probl Surg (1995) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53